Prestige Consumer Healthcare (PBH) stock
PBH's Quality Score rose 2 points on Mon, Oct 5, to 1. Closed near the day's high (2 chart checks started).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Why it's down
Down 49% from its 5-year high in May 2025. The S&P 500 rose 30% over the same stretch.
Its industry held up: the 80 other stocks in it rose a median 29% over the same stretch.
−3Long-term trend below a falling 200-day average, down over one year, down over two years
1 more thing pulling PBH's score down, for Pro members
What's next
Expected to report Thu Nov 5, before the open
After its last 4 reports it closed -2.1% on average, higher 2 of 4 times.
What would turn PBH's score around: 6 things, for Pro members
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
PBH has 4 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1440.7
- MACD (12, 26, 9)Below signal
- 50-day average$49.82
- 200-day average$55.47
- ADX 1427.2
- Support$45.22
- Resistance$49.20
- Bollinger Bands (20, 2)Inside
- Volume1.0x
How PBH ranks in Pharma
PBH is #46 of 91 by Quality Score. The top three are shown with their scores, and more by name.
ABBV10/1421
GMAB8/1416
CYRX8/1413
OPKOpen for its score
ORGOOpen for its score
PFEOpen for its score
PGENOpen for its score
PBH4/141
When does PBH report earnings, and what happens after?
Expected to report Thu Nov 5, before the open (in 30 days). Not yet confirmed by the company.
| Reported | When | Gap | Reaction | 5 sessions |
|---|---|---|---|---|
| Aug 6, 2026Before open | Before open | +4.6% | +2.7% | -1.3% |
| May 13, 2026After close | After close | -7.2% | -11.3% | -8.9% |
| Feb 5, 2026Before open | Before open | -4.4% | -2.2% | -1.6% |
| Nov 6, 2025Before open | Before open | +2.1% | +2.6% | +1.1% |
Who is trading PBH
PBH trades by Congress and the White House
2 trades disclosed in the last six months. The newest:
About Prestige Consumer Healthcare
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of PBH's score, with the points and the reason
- All 14 checks on PBH and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on PBH
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.